参芪花粉片联合β受体阻滞剂治疗血管迷走性晕厥疗效观察(3)
第1页 |
参见附件。
[3] 杨莉.厄贝沙坦片联合琥珀酸美托洛尔缓释片治疗血管迷走性晕厥疗效观察[J].医学信息,2013(7):328-329.
[4] Leo M, Betts T. Risk stratification key in patients with syncope [J] .The Practitioner, 2012, 257(1766):15-19, 12.
[5] Heeger CH, Rillig A, Ouyang F, et al.Syncope:Epidemiology, definition, classification, pathophysiology and prognosis [J].Herz,2014.
[6] Kochiadakis GE, Papadimitriou EA, Marketou ME, et al. Autonomic nervous system changes in vasovagal syncope: is there any difference between young and older patients? [J]. Pacing and Clinical Electrophysiology:PACE,2004,27(10):1371-1377.
[7] Jardine D.Vasovagal syncope: New physiologic insights[J].Cardiology Clinics,2013,31(1):75-87.
[8] Aydin MA, Salukhe TV, Wilke I, et al.Management and therapy of vasovagal syncope: A review [J] . World Journal of Cardiology,2010,2(10):308-315.
[9] Brignole M. Diagnosis and treatment of syncope [J]. Heart, 2007,93(1):130-136.
[10] Liao Y, Li XY, Zhang YW, et al. Meta-analysis of beta-adrenoceptor blockers for the treatment of vasovagal syncope [J]. Journal of Peking University Health Sciences,2008,40(6):603-609.
[11] 李庆.黄芪的药理药效研究进展[J].中国医药导报,2006(11):128-129.
[12] 仝欣.黄芪主要活性成分的药理作用[J].时珍国医国药,2011,22(5):1246-1249.
[13] 刘艳萍,何开明,黄小艳.黄芪注射液穴位注射治疗血管迷走性晕厥的临床观察[J].西部医学,2012,24 (11):2181-2182.
[14] 韩阳,王战坤,王招娣,等.复方丹参滴丸治疗血管迷走性晕厥的疗效观察[J].中国中西医结合杂志,2004,24(5):452-454.
[15] 周小鹭.花粉的药理及应用研究[J].黑龙江医药,2009,22(2):152-155.
[16] 查益中.黄芪对血压的双相调节作用[J].中医杂志,2000,41(6):329.
(收稿日期:2014-04-08)
您现在查看是摘要介绍页,详见PDF附件。